Physicochemical, pharmacokinetic, and pharmacodynamic characterization of isradipine tablets for controlled release

References

• Abdel-Rahman SI, Mahrous GM, El-Badry M. 2009. Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets. Saudi Pharm J. 17(4):283–288.
   PubMedGoogle Scholar
• Agarwal S, Murthy RSR. 2015. Effect of different polymer concentration on drug release rate and physicochemical properties of mucoadhesive gastroretentive tablets. Ind J Pharm Sci. 77(6):705–714.
   PubMed Web of Science ®Google Scholar
• Andreani T, Fangueiro JF, Jose S, Santini A, Silva AM, Souto EB. 2015. Hydrophilic polymers for modified-release nanoparticles: a review of mathematical modelling for pharmacokinetic analysis. Curr Pharm Des. 21(22):3090–3096.
   PubMed Web of Science ®Google Scholar
• Aslani A, Fattahi F. 2013. Formulation, characterization and physicochemical evaluation of potassium citrate effervescent tablets. Adv Pharm Bull. 3(1):217–225.
   PubMedGoogle Scholar
• Borgquist P, Körner A, Piculell L, Larsson A, Axelsson A. 2006. A model for the drug release from a polymer matrix tablet—effects of swelling and dissolution. J Control Release. 113(3):216–225.
   PubMed Web of Science ®Google Scholar
• Bose A, Wong TW, Singh N. 2013. Formulation development and optimization of sustained release matrix tablet of itopride HCl by response surface methodology and its evaluation of release kinetics. Saudi Pharm J. 21(2):201–213.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Hatton GB, Merchant HA, Basit AW. 2015. Gastrointestinal release behaviour of modified-release drug products: dynamic dissolution testing of mesalazine formulations. Int J Pharm. 484(1–2):103–108.
   PubMed Web of Science ®Google Scholar
• Grossman E, Messerli FH, Oren S, Nunez B, Garavaglia GE. 1991. Cardiovascular effects of isradipine in essential hypertension. Am J Cardiol. 68(1):65–70.
   PubMed Web of Science ®Google Scholar
• Hill S, Varker AS, Karlage K, Myrdal PB. 2009. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm. 15(3):253–261.
   PubMed Web of Science ®Google Scholar
• Hiremath PS, Saha RN. 2008. Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies. AAPS PharmSciTech. 9(4):1171–1178.
   PubMed Web of Science ®Google Scholar
• Hof RP, Rüegg UT. 1988. Pharmacology of the new calcium antagonist isradipine and its metabolites. Am J Med. 84(3):13–17.
   PubMed Web of Science ®Google Scholar
• Huang Y-T, Tsai T-R, Cheng C-J, Cham T-M, Lai T-F, Chuo W-H. 2007. Formulation design of an HPMC-based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties. Drug Dev Ind Pharm. 33(11):1183–1191.
   PubMed Web of Science ®Google Scholar
• Ilijic E, Guzman JN, Surmeier DJ. 2011. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease. Neurobiol Dis. 43(2):364–371.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Javors MA, Lam Y-WF, Wells LT, Tiouririne M, Roache JD, Ait-Daoud N, Lawson K. 2005. Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals. Prog Neuropsychopharmacol Biol Psychiatry. 29(1):15–20.
   PubMed Web of Science ®Google Scholar
• Joshi SC. 2011. Sol–gel behavior of hydroxypropyl methylcellulose (HPMC) in ionic media including drug release. Materials (Basel). 4(10):1861–1905.
   PubMed Web of Science ®Google Scholar
• Kaleemullah M, Jiyauddin K, Thiban E, Rasha S, Al-Dhalli S, Budiasih S, Gamal OE, Fadli A, Eddy Y. 2017. Development and evaluation of ketoprofen sustained release matrix tablet using Hibiscus rosa-sinensis leaves mucilage. Saudi Pharm J. 25(5):770–779.
   PubMed Web of Science ®Google Scholar
• Kaunisto E, Marucci M, Borgquist P, Axelsson A. 2011. Mechanistic modelling of drug release from polymer-coated and swelling and dissolving polymer matrix systems. Int J Pharm. 418(1):54–77.
   PubMed Web of Science ®Google Scholar
• Khan R, Ashraf MS, Afzal M, Kazmi I, Jahangir MA, Singh R, Chandra R, Anwar F. 2014. Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique. J Pharm Bioallied Sci. 6(3):180–184.
   PubMedGoogle Scholar
• Krukiewicz K, Stokfisz A, Zak JK. 2015. Two approaches to the model drug immobilization into conjugated polymer matrix. Mater Sci Eng C Mater Biol Appl. 54:176–181.
   PubMed Web of Science ®Google Scholar
• Kumar V, Kharb R, Chaudhary H. 2016. Optimization & design of isradipine loaded solid lipid nanobioparticles using rutin by Taguchi methodology. Int J Biol Macromol. 92:338–346.
   PubMed Web of Science ®Google Scholar
• Li H, Hardy RJ, Gu X. 2008. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets. AAPS PharmSciTech. 9(2):437–443.
   PubMed Web of Science ®Google Scholar
• Lindberg NO, Pålsson M, Pihl AC, Freeman R, Freeman T, Zetzener H, Enstad G. 2004. Flowability measurements of pharmaceutical powder mixtures with poor flow using five different techniques. Drug Dev Ind Pharm. 30(7):785–791.
   PubMed Web of Science ®Google Scholar
• Löbenberg R, Kim JS, Amidon GL. 2005. Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs. Eur J Pharm Biopharm. 60(1):17–23.
   PubMed Web of Science ®Google Scholar
• Marasini N, Haque S, Kaminskas LM. 2017. Polymer–drug conjugates as inhalable drug delivery systems: a review. Curr Opin Colloid Interface Sci. 31:18–29.
   Web of Science ®Google Scholar
• Masterson VM, Cao X. 2008. Evaluating particle hardness of pharmaceutical solids using AFM nanoindentation. Int J Pharm. 362(1–2):163–171.
   PubMed Web of Science ®Google Scholar
• Navaneethan CV, Missaghi S, Fassihi R. 2005. Application of powder rheometer to determine powder flow properties and lubrication efficiency of pharmaceutical particulate systems [journal article. AAPS PharmSciTech. 6(3):E398–E404.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Raja S, Patel P, Asare-Addo K. 2012. The role of oral controlled release matrix tablets in drug delivery systems. BioImpacts. 2(4):175–187.
   PubMedGoogle Scholar
• Osei-Yeboah F, Sun CC. 2015. Validation and applications of an expedited tablet friability method. Int J Pharm. 484(1–2):146–155.
   PubMed Web of Science ®Google Scholar
• Rinaki E, Dokoumetzidis A, Macheras P. 2003. The mean dissolution time depends on the dose/solubility ratio. Pharm Res. 20(3):406–408.
   PubMed Web of Science ®Google Scholar
• Sahu P, Kashaw SK, Kushwah V, Sau S, Jain S, Iyer AK. 2017. pH responsive biodegradable nanogels for sustained release of bleomycin. Bioorg Med Chem. 25(17):4595–4613.
   PubMed Web of Science ®Google Scholar
• Schiavi P, Jochemsen R, Guez D. 2000. Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers. Fundam Clin Pharmacol. 14(2):139–146.
   PubMed Web of Science ®Google Scholar
• Schran HF, Jaffe JM, Gonasun LM. 1988. Clinical pharmacokinetics of isradipine. Am J Med. 84(3):80–89.
   PubMed Web of Science ®Google Scholar
• Schüssele A, Bauer-Brandl A. 2003. Note on the measurement of flowability according to the European Pharmacopoeia. Int J Pharm. 257(1–2):301–304.
   PubMed Web of Science ®Google Scholar
• Severino P, Szymanski M, Favaro M, Azzoni AR, Chaud MV, Santana MH, Silva AM, Souto EB. 2015. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy. Eur J Pharm Sci. 66:78–82.
   PubMed Web of Science ®Google Scholar
• Shah KU, Khan GM. 2012. Regulating drug release behavior and kinetics from matrix tablets based on fine particle-sized ethyl cellulose ether derivatives: an in vitro and in vivo evaluation. Sci World J. 2012:1–8.
   Web of Science ®Google Scholar
• Shah RB, Tawakkul MA, Khan MA. 2008. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech. 9(1):250–258.
   PubMed Web of Science ®Google Scholar
• Shanmugam S. 2015. Granulation techniques and technologies: recent progresses. Bioimpacts. 5(1):55–63.
   PubMed Web of Science ®Google Scholar
• Shen J, Burgess DJ. 2013. In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug Deliv Transl Res. 3(5):409–415.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. 2011. Higuchi equation: derivation, applications, use and misuse. Int J Pharm. 418(1):6–12.
   PubMed Web of Science ®Google Scholar
• Solanki NG, Tahsin M, Shah AV, Serajuddin ATM. 2018. Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: screening polymers for drug release, drug–polymer miscibility and printability. J Pharm Sci. 107(1):390–401.
   PubMed Web of Science ®Google Scholar
• Souto EB, Severino P, Marques C, Andrade LN, Durazzo A, Lucarini M, Atanasov AG, El Mamouni S, Santini A. 2020. Croton argyrophyllus Kunth essential oil – loaded SLN: evaluation of release profile, antioxidant activity and cytotoxicity in a neuroblastoma cell line. Biomolecules; submitted for publication.
   Google Scholar
• Staessen J, Fagard R, Lijnen P, Amery A. 1988. Acute effects of isradipine on angiotensin II responsiveness. Am J Med. 84(3):67–71.
   PubMedGoogle Scholar
• Steinijans VW. 1990. Pharmacokinetic characterization of controlled-release formulations. Eur J Drug Metab Pharmacokinet. 15(2):173–181.
   PubMed Web of Science ®Google Scholar
• Tavares JK, de Souza AAU, de Oliveira JV, Priamo WL, de Souza S. 2016. Modeling of the controlled release of betacarotene into anhydrous ethanol from microcapsules. OpenNano. 1:25–35.
   Google Scholar
• Tran PH, Tran TT, Piao ZZ, Vo TV, Park JB, Lim J, Oh KT, Rhee YS, Lee BJ. 2013. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion. Int J Pharm. 450(1–2):79–86.
   PubMed Web of Science ®Google Scholar
• Van Den Berg EK, Dehmer GJ. 1988. Acute hemodynamic effects of intravenous isradipine. Am J Cardiol. 61(13):1102–1105.
   PubMed Web of Science ®Google Scholar
• Vanarase AU, Osorio JG, Muzzio FJ. 2013. Effects of powder flow properties and shear environment on the performance of continuous mixing of pharmaceutical powders. Powder Technol. 246:63–72.
   Web of Science ®Google Scholar
• Varum FJO, Merchant HA, Basit AW. 2010. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption. Int J Pharm. 395(1–2):26–36.
   PubMed Web of Science ®Google Scholar
• Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR. 1999. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release. 57(1):75–85.
   PubMed Web of Science ®Google Scholar
• Venkatesh DN, Meyyanathan SN, Shanmugam R, Zielinska A, Campos JR, Ferreira JD, Souto EB. 2020a. Sustained-release nateglinide tablets: formulation development, in vitro release and in vivo bioavailability. J Drug Deliv Sci Technol. 55:101355.
   Web of Science ®Google Scholar
• Venkatesh DN, Meyyanathan SN, Shanmugam R, Zielinska A, Campos JR, Ferreira JD, Souto EB. 2020b. Development, in vitro release and in vivo bioavailability of sustained release nateglinide tablets. J Drug Deliv Sci Technol. 55:101355.
   Web of Science ®Google Scholar
• Wang L, Feng R, Gao J, Xi Y, Huang G. 2016. Generic sustained release tablets of trimetazidine hydrochloride: preparation and in vitro–in vivo correlation studies. Asian J Pharm Sci. 11(3):417–426.
   Web of Science ®Google Scholar
• Williams HD, Ward R, Hardy IJ, Melia CD. 2009. The extended release properties of HPMC matrices in the presence of dietary sugars. J Control Release. 138(3):251–259.
   PubMed Web of Science ®Google Scholar
• Yassin S, Su K, Lin H, Gladden LF, Zeitler JA. 2015. Diffusion and swelling measurements in pharmaceutical powder compacts using terahertz pulsed imaging. J Pharm Sci. 104(5):1658–1667.
   PubMed Web of Science ®Google Scholar
• Yin J, Wang W, Xu X, Li H, Cong M, Zhao X, Wang C. 2018. Preparation, characterization and pharmacokinetics of extended-release tablets of marine polysaccharide drug. J Drug Deliv Sci Technol. 43:353–361.
   Web of Science ®Google Scholar
• Yuen K-H. 2010. The transit of dosage forms through the small intestine. Int J Pharm. 395(1–2):9–16.
   PubMed Web of Science ®Google Scholar
• Zaid AN, Al-Ramahi RJ, Ghoush AA, Qaddumi A, Zaaror YA. 2013. Weight and content uniformity of lorazepam half-tablets: a study of correlation of a low drug content product. Saudi Pharm J. 21(1):71–75.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Janssens L, Verhaeghe T, Robert Brashear H, Truyen L. 2005. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers. Curr Med Res Opin. 21(10):1547–1554.
   PubMed Web of Science ®Google Scholar
• Zilberman EN, Lerner F, Joseph HM, Alon M. 1993. Properties of hydroxypropyl methylcellulose–polyvinyl alcohol water systems, dispersants in vinyl chloride suspension polymerization. J Appl Polym Sci. 48(3):435–442.
   Web of Science ®Google Scholar